Cyclooxygenases and cyclooxygenase inhibitors: is a new class of drugs in the making?
Berenbaum, F.
Revue du Rhumatisme 65(11): 634-640
1998
ISSN/ISBN: 1169-8446 PMID: 9850532 Document Number: 496873
Document emailed within 1 workday
Related Documents
Sherer, Y.; Bar-Dayan, Y.; Shoenfeld, Y. 1997: Selective inhibitors of cyclooxygenase-2 in upgrade in nonsteroidal anti-inflammatory drugs Harefuah 132(6): 411-416Petzinger, E. 1991: Gyrase inhibitors, a new class of therapeutic drugs Tierarztliche Praxis 19(1): 14-20
Koopmans, P.P. 2003: Enfuvirtide, the first representative of a new class of drugs for the treatment of HIV infection : HIV fusion inhibitors Nederlands Tijdschrift Voor Geneeskunde 147(36): 1726-1729
Dzielska-Olczak, M.łg. 2011: Cyclooxygenases inhibitors and other compounds with antiinflammatory potential in osteoarthrosis--part Ii Polski Merkuriusz Lekarski: Organ Polskiego Towarzystwa Lekarskiego 30(175): 82-86
Pötsch, S.; Drechsler, H.; Liermann, B.; Gräslund, A.; Lassmann, G. 1994: P-Alkoxyphenols, a new class of inhibitors of mammalian R2 ribonucleotide reductase: possible candidates for antimelanotic drugs Molecular Pharmacology 45(4): 792-796
Kawai, S. 2002: Recent development of selective cyclooxygenase-2 inhibitors Nihon Rinsho. Japanese Journal of Clinical Medicine 60(12): 2370-2377
Masferrer, J.L. 2003: Cyclooxygenase-2 inhibitors in cancer prevention and treatment Advances in Experimental Medicine and Biology 532: 209-213
Huddle, K.; Milne, F.J. 1991: Should ACE inhibitors be the drugs of choice in the treatment of hypertension in diabetes mellitus? ACE inhibitors are the drugs of choice in diabetic nephropathy South African Medical Journal 80(5): Suppl 10
Fraenkel, L.; Wittink, D.R.; Concato, J.; Fried, T. 2004: Are preferences for cyclooxygenase-2 inhibitors influenced by the certainty effect? Journal of Rheumatology 31(3): 591-593
Ranger, G.Singh. 2014: Current concepts in colorectal cancer prevention with cyclooxygenase inhibitors Anticancer Research 34(11): 6277-6282
Jin, X-feng.; Tong, J-lu.; Ran, Z-hua. 2007: Selective cyclooxygenase-2 inhibitors for the prevention of colorectal adenomas: a meta-analysis Zhonghua Yi Xue Za Zhi 87(28): 1958-1961
Cohen-Luria, R.; Moran, A.; Rimon, G. 1994: Cyclooxygenase inhibitors suppress inhibitory effect of PGE2 on Na-K-ATPase in MDCK cells American Journal of Physiology 267(1 Pt 2): F94-F98
Olsen, S.C.; Coyne, C.P.; Lowe, B.S.; Pelletier, N.; Raub, E.M.; Erickson, H.H. 1992: Influence of cyclooxygenase inhibitors on furosemide-induced hemodynamic effects during exercise in horses American Journal of Veterinary Research 53(9): 1562-1567
Trimboli, A.J.; Waite, B.M.; Atsumi, G.; Fonteh, A.N.; Namen, A.M.; Clay, C.E.; Kute, T.E.; High, K.P.; Willingham, M.C.; Chilton, F.H. 1999: Influence of coenzyme A-independent transacylase and cyclooxygenase inhibitors on the proliferation of breast cancer cells Cancer Research 59(24): 6171-6177
Bujalska, M. 2003: Effect of cyclooxygenase and NO synthase inhibitors administered centrally on antinociceptive action of acetaminophen (Part II) Polish Journal of Pharmacology 55(6): 1001-1011
Verburg, A.F.E.; van den Donk, M.; Wiersma, T. 2019: Application of new glucose lowering drugs: DPP-4 inhibitors, GLP-1 receptor agonists and SGLT-2 inhibitors Nederlands Tijdschrift Voor Geneeskunde 163
Karateev, A.E. 2014: Selective cyclooxygenase-2 inhibitors and protected nonsteroidal anti-inflammatory agents: two methods for the prevention of iatrogenic complications Klinicheskaia Meditsina 92(8): 54-61
Bonnici, F.; Omar, M.A. 1991: Should ACE inhibitors be the drugs of choice in the treatment of hypertension in diabetes mellitus? ACE inhibitors have a more beneficial effect on biochemical parameters than low-dose thiazides South African Medical Journal 80(5): Suppl 6
Bekemeier, H.; Hirschelmann, R.; Ramanampison, M.L.; Pantović, D. 1986: Simultaneous and sequential inhibition of the arachidonic acid cascade by inhibitors of phospholipase A2, cyclooxygenase and lipoxygenases in carrageenan edema and adjuvant arthritis in the rat Die Pharmazie 41(6): 406-408
Kruse, R.; Ruzicka, T.; Grewe, M. 2003: Intolerance reactions due to the selective cyclooxygenase type II inhibitors rofecoxib and celecoxib. Results of oral provocation tests in patients with NSAID hypersensitivity Acta Dermato-Venereologica 83(3): 183-185